{"id":38897,"date":"2025-08-08T17:31:23","date_gmt":"2025-08-08T09:31:23","guid":{"rendered":"https:\/\/flcube.com\/?p=38897"},"modified":"2025-08-08T17:31:24","modified_gmt":"2025-08-08T09:31:24","slug":"viatris-reports-q2-revenue-drop-sees-growth-in-greater-china-amid-global-decline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38897","title":{"rendered":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">US-based generics firm Viatris Inc. (<a href=\"https:\/\/www.google.com\/finance\/quote\/VTRS:NASDAQ\">NASDAQ: VTRS<\/a>) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Regional Performance<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Greater China<\/strong>: The only region with growth, achieving a 9% sales increase to USD 588.9 million.<\/li>\n\n\n\n<li><strong>Developed Markets<\/strong>: Sales fell by 11% to USD 2.12 billion.<\/li>\n\n\n\n<li><strong>Emerging Markets<\/strong>: Declined by 3% to USD 555.1 million.<\/li>\n\n\n\n<li><strong>JANZ Region<\/strong>: Experienced a 14% decrease to USD 305.7 million.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Impact of FDA Warning<\/strong><br>The FDA warning letter and import alert issued in December 2024 had a significant financial impact, resulting in a USD 160 million loss in Q2 and USD 300 million over the first half of 2025. CEO Scott Andrew Smith indicated during the earnings call that the company is approximately 80% remediated in its Indore facility and plans to meet with the FDA soon to resolve the remaining issues.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>China Market Insights<\/strong><br>Chief Commercial Officer Corinne M. Le Goff attributed the growth in Greater China to the company&#8217;s diversified commercial model, which includes e-commerce, retail, and private hospitals. She noted that about 95% of Viatris&#8217; portfolio is included in the national Volume-Based Procurement (VBP) program, which helps reduce market uncertainty. Patients continue to show consistent demand for Viatris&#8217; well-established brands. The company expects China&#8217;s growth to moderate to low- to mid-single digits for the remainder of the year.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/VTRS-Q2-2025-Earnings-Presentation-FINAL.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of VTRS Q2 2025 Earnings Presentation - FINAL.\"><\/object><a id=\"wp-block-file--media-641fe787-2a44-4798-89a6-ebae1c764394\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/VTRS-Q2-2025-Earnings-Presentation-FINAL.pdf\">VTRS Q2 2025 Earnings Presentation &#8211; FINAL<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/VTRS-Q2-2025-Earnings-Presentation-FINAL.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-641fe787-2a44-4798-89a6-ebae1c764394\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7%&#8230;<\/p>\n","protected":false},"author":1,"featured_media":38899,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[27,1018,207],"class_list":["post-38897","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-finanical-reports","tag-nasdaq-vtrs","tag-viatris"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38897\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline\" \/>\n<meta property=\"og:description\" content=\"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38897\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-08T09:31:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T09:31:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline\",\"datePublished\":\"2025-08-08T09:31:23+00:00\",\"dateModified\":\"2025-08-08T09:31:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897\"},\"wordCount\":253,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0802-1.webp\",\"keywords\":[\"Finanical Reports\",\"NASDAQ: VTRS\",\"Viatris\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38897#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38897\",\"name\":\"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0802-1.webp\",\"datePublished\":\"2025-08-08T09:31:23+00:00\",\"dateModified\":\"2025-08-08T09:31:24+00:00\",\"description\":\"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38897\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0802-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0802-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38897#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline - Insight, China&#039;s Pharmaceutical Industry","description":"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38897","og_locale":"en_US","og_type":"article","og_title":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline","og_description":"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.","og_url":"https:\/\/flcube.com\/?p=38897","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-08T09:31:23+00:00","article_modified_time":"2025-08-08T09:31:24+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38897#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38897"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline","datePublished":"2025-08-08T09:31:23+00:00","dateModified":"2025-08-08T09:31:24+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38897"},"wordCount":253,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38897#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","keywords":["Finanical Reports","NASDAQ: VTRS","Viatris"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38897#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38897","url":"https:\/\/flcube.com\/?p=38897","name":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38897#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38897#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","datePublished":"2025-08-08T09:31:23+00:00","dateModified":"2025-08-08T09:31:24+00:00","description":"US-based generics firm Viatris Inc. (NASDAQ: VTRS) reported Q2 2025 financial results, showing a 7% year-on-year decrease in global revenues to USD 3.58 billion. This decline was driven by challenges including an FDA warning letter and import alert related to its manufacturing facility in Indore, India.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38897#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38897"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38897#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","width":1080,"height":608,"caption":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38897#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Viatris Reports Q2 Revenue Drop, Sees Growth in Greater China Amid Global Decline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0802-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38897"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38897\/revisions"}],"predecessor-version":[{"id":38900,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38897\/revisions\/38900"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38899"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}